OraSure Technologies (OSUR)
OraSure Technologies Earnings Yield
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
OSUR Earnings Yield Range, Past 5 Years
| Minimum | -32.79% | Jun 2009 |
| Maximum | 1.34% | Jun 2007 |
| Average | -6.74% |
About Earnings Yield
Earnings yield is earnings per share from the previous four quarters divided by the share price. It is the reciprocal of the P/E ratio. The earnings yield is quoted as a percentage, which illustrates the percentage of each dollar invested that was earned by the company during the past twelve months.
The earnings yield can be used to compare the earnings of a stock, sector or the whole market against bond yields. Generally, the earnings yields of equities are higher than the yield of risk-free treasury bonds. Financial theorists argue that this difference exists because stock earnings are riskier than bond coupon payments.
If a company has an earnings yield of 64%, investors are purchasing $0.64 of earnings per dollar invested.
Learn More
You may also be interested in these OSUR related companies
OSUR News
OraSure Technologies to Present at Jefferies 2012 Global Healthcare Conference
May 29, 6:00AM GlobeNewswire
May 29, 6:00AM GlobeNewswire
$OSUR Insider Sale: $1M of stock sold by Ronald Spair on May 16, 2012 http://stks.co/3tz7
about 13 days ago by MarketBrief
about 13 days ago by MarketBrief
OraSure Technologies Applauds CDC Proposed Draft Guidelines for Testing of Baby Boomers for Hepatitis C
May 18, 2:59PM GlobeNewswire
May 18, 2:59PM GlobeNewswire
OraSure Technologies Announces Rapid HCV Testing Initiatives for First National Hepatitis Testing Day
May 18, 8:49AM GlobeNewswire
May 18, 8:49AM GlobeNewswire
Top Winners last Wednesday, May 16, 2012
#NASDAQ :
$ROSG,$FNBN,$TELK,$OSUR,$NLST #Stocks #StockMarket #invest
about 14 days ago by MarkeScope
about 14 days ago by MarkeScope
$OSUR although great news for humanity, I just got out with pretty big loss and big lesson learned, "sell on news" now in $UVXY
about 14 days ago by leahcim474
about 14 days ago by leahcim474
$ROSG http://stks.co/3rgc $ROSG $P $CTRN $VELT $DORM $OSUR. Full blog post here http://stks.co/3rgd
about 15 days ago by LincolnList
about 15 days ago by LincolnList
$OSUR ready to break back up to 12's here. Rmember bios run better on fda panel recommendation then pdufs evn and $OSUR got 17-0 unan vote !
about 15 days ago by epime7heus
about 15 days ago by epime7heus
RT @Captain_Power: $OSUR waiting for it ~~> to take off, get in before bell
about 15 days ago by leahcim474
about 15 days ago by leahcim474
$OSUR true, much stigma about AIDS, but organizations around the world will buy many to give for those in need http://stks.co/3rEJ
about 15 days ago by leahcim474
about 15 days ago by leahcim474
$OSUR profits from those who held for this event is done, new people interested in the true potential of HIV tests in every store are IN
about 15 days ago by leahcim474
about 15 days ago by leahcim474
$OSUR $11.50 by end of day and peak out at little over $12 early tomorrow then probably down
about 15 days ago by leahcim474
about 15 days ago by leahcim474
$OSUR Shorts will cover down low. It will come back up, then we short again.
about 15 days ago by 941investor
about 15 days ago by 941investor
Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); FDA Panel Supports HIV-OTC
May 16, 9:28AM Street Insider
May 16, 9:28AM Street Insider
OraSure's (OSUR) OraQuick Receives Unanimous Recommendation from FDA Panel
May 15, 5:58PM Street Insider
May 15, 5:58PM Street Insider
OraQuick(R) In-Home HIV Test Receives Unanimous Positive Recommendation From FDA Advisory Committee
May 15, 5:56PM GlobeNewswire
May 15, 5:56PM GlobeNewswire
FDA Panel Votes 17-0 In Favor of Safety, Effectiveness of OraSure's (OSUR) At-Home HIV Test
May 15, 4:42PM Street Insider
May 15, 4:42PM Street Insider
OraSure Technologies' CEO Presents at Deutsche Bank AG Health Care Conference (Transcript)
May 07, 2:29PM Seeking Alpha
May 07, 2:29PM Seeking Alpha
Canaccord Genuity Maintains a 'Buy' on OraSure Technologies (OSUR); Focus on 2012 Catalysts
May 03, 9:59AM Street Insider
May 03, 9:59AM Street Insider
OraSure Technologies, Inc. (OSUR) Tops Q1 EPS by 1c; Issues Light Q2 Outlook
May 02, 4:30PM Street Insider
May 02, 4:30PM Street Insider
OraSure Technologies to Present at Deutsche Bank's 37th Annual Health Care Conference
Apr 30, 6:00AM GlobeNewswire
Apr 30, 6:00AM GlobeNewswire
Benchmark Starts Chembio Diagnostics (CEMI) at Speculative Buy; Potential Over-the-Counter HIV Resting Market
Apr 24, 8:29AM Street Insider
Apr 24, 8:29AM Street Insider
FDA Sets Date for Advisory Committee Review of OraSure Over-the-Counter Rapid HIV Test
Apr 04, 10:50AM Benzinga
Apr 04, 10:50AM Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| OSUR | 10.38 | +0.07 | +0.63% | 496.74M |
| OSTK | 6.66 | +0.12 | +1.83% | 153.17M |
| OSN | 0.9161 | -0.03 | -3.57% | 18.32M |
| OSIS | 63.79 | +0.09 | +0.14% | 1.259B |
| OSIR | 6.32 | -0.66 | -9.46% | 229.15M |
| OSHC | 11.98 | -0.02 | -0.17% | 87.48M |
| OSG | 10.93 | -0.08 | -0.73% | 335.25M |
| OSBC | 1.33 | +0.07 | +5.56% | 17.74M |
| ORRF | 7.55 | +0.03 | +0.40% | 60.61M |
| ORLY | 95.85 | +0.13 | +0.14% | 12.16B |
